Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1385520rdf:typepubmed:Citationlld:pubmed
pubmed-article:1385520lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0596902lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C1637379lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:1385520lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:1385520pubmed:issue10lld:pubmed
pubmed-article:1385520pubmed:dateCreated1992-12-8lld:pubmed
pubmed-article:1385520pubmed:abstractTextTransporter in Ag processing-1 (TAP-1, previously called PSF-1 or Ring-4) is an MHC-encoded gene product that is required for efficient association of intracellular peptide Ag with nascent HLA class I H chain and beta 2-microglobulin, thereby permitting assembly and normal surface expression of the class I molecules. TAP-1 is thought to function as a component of a transmembrane pump, that transports cytoplasmically-derived peptides into the lumen of the endoplasmic reticulum where class I molecules assemble. Synthesis and expression of HLA class I molecules is increased in human endothelial cells by IFN-beta, IFN-gamma, and TNF. We report these same cytokines increase TAP-1 expression. As with class I, TAP-1 is also synergistically increased by combinations of TNF with IFN. Interestingly, cytokine-induced increases in TAP-1 mRNA are markedly more rapid than increases in class I mRNA. This rapid increase in TAP-1 mRNA is reflected in a rapid increase in TAP-1 protein. These results demonstrate that TAP-1 synthesis and class I synthesis are regulated in parallel. The rapidity of the cytokine response of TAP-1 compared to class I further suggests that the constitutive level of TAP-1 expression in endothelial cells is not sufficient to support inducible increases in class I expression.lld:pubmed
pubmed-article:1385520pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:languageenglld:pubmed
pubmed-article:1385520pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1385520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385520pubmed:statusMEDLINElld:pubmed
pubmed-article:1385520pubmed:monthNovlld:pubmed
pubmed-article:1385520pubmed:issn0022-1767lld:pubmed
pubmed-article:1385520pubmed:authorpubmed-author:SpierWWlld:pubmed
pubmed-article:1385520pubmed:authorpubmed-author:PoberJ SJSlld:pubmed
pubmed-article:1385520pubmed:authorpubmed-author:CresswellPPlld:pubmed
pubmed-article:1385520pubmed:authorpubmed-author:JohnsonD RDRlld:pubmed
pubmed-article:1385520pubmed:authorpubmed-author:ArnoldDDlld:pubmed
pubmed-article:1385520pubmed:authorpubmed-author:EppersonD EDElld:pubmed
pubmed-article:1385520pubmed:issnTypePrintlld:pubmed
pubmed-article:1385520pubmed:day15lld:pubmed
pubmed-article:1385520pubmed:volume149lld:pubmed
pubmed-article:1385520pubmed:ownerNLMlld:pubmed
pubmed-article:1385520pubmed:authorsCompleteYlld:pubmed
pubmed-article:1385520pubmed:pagination3297-301lld:pubmed
pubmed-article:1385520pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:meshHeadingpubmed-meshheading:1385520-...lld:pubmed
pubmed-article:1385520pubmed:year1992lld:pubmed
pubmed-article:1385520pubmed:articleTitleCytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells.lld:pubmed
pubmed-article:1385520pubmed:affiliationBoyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06510.lld:pubmed
pubmed-article:1385520pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1385520pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1385520pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1385520lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1385520lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1385520lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1385520lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1385520lld:pubmed